Regis Healthcare Limited

ASX:REG.AX

6.65 (AUD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q2
Revenue 533.975475.657394.717376.765357.582360.313344.24341.627338.684327.468322.894318.228298.474295.923280.757284.726244.134236.611218.313219.195208.933200.61
Cost of Revenue 442.509459.348397.589377.675385.855326.864323.273295.054298.85280.017266.734236.603219.02213.316197.266200.995173.739166.811156.253148.502122.814115.317
Gross Profit 91.46616.309-2.872-0.91-28.27333.44920.96746.57339.83447.45156.1681.62579.45482.60783.49183.73170.39569.862.0670.69386.11985.293
Gross Profit Ratio 0.1710.034-0.007-0.002-0.0790.0930.0610.1360.1180.1450.1740.2560.2660.2790.2970.2940.2880.2950.2840.3230.4120.425
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 21.24716.31433.82614.32620.90221.71620.22419.32720.33517.9416.12716.68110.6416.99612.42413.6339.56511.86811.05312.3977.4231.917
Selling & Marketing Expenses 15.57425.50915.32811.639-13.34512.00512.75210.6258.04110.72210.5410.2199.2528.7588.6287.9586.7576.0876.0055.7481.17718.737
SG&A 36.82141.82349.15436.4567.55733.72132.97629.95228.37628.66226.66726.919.89225.75421.05221.59116.32217.95517.05818.14533.0220.654
Other Expenses 0000000000000000000000
Operating Expenses 36.82141.82349.15436.4567.55733.72132.97629.95228.37628.66226.66742.17737.89639.1938.23235.36940.1429.027.50439.12673.13852.098
Operating Income 54.645-25.514-52.026-37.366-35.83-0.272-12.00916.62111.45818.78929.49338.38145.96742.86646.09448.9843.02341.04134.74743.8898.77336.638
Operating Income Ratio 0.102-0.054-0.132-0.099-0.1-0.001-0.0350.0490.0340.0570.0910.1210.1540.1450.1640.1720.1760.1730.1590.20.0420.183
Total Other Income Expenses Net -68.13610.90148.1370.875-14.223-4.8625.298-0.76-16.61-1.5196.116-4.363-9.009-3.052-3.608-3.748-13.34-0.64318.167-18.717-8.298-11.485
Income Before Tax -13.491-14.613-3.889-36.491-50.053-5.13213.28915.861-5.15217.2735.60934.01836.95839.81442.48645.23229.68340.39852.91425.1720.47525.153
Income Before Tax Ratio -0.025-0.031-0.01-0.097-0.14-0.0140.0390.046-0.0150.0530.110.1070.1240.1350.1510.1590.1220.1710.2420.1150.0020.125
Income Tax Expense 4.218-2.471-1.347-10.582-14.923-1.4634.3434.8583.1685.1869.1119.61910.96411.93913.02413.59311.42712.11910.51210.0616.1838.397
Net Income -9.273-12.142-2.542-25.909-35.13-3.6698.94611.003-8.3212.08426.49824.39925.99427.87529.46231.63918.25628.27942.40215.112-15.70816.756
Net Income Ratio -0.017-0.026-0.006-0.069-0.098-0.010.0260.032-0.0250.0370.0820.0770.0870.0940.1050.1110.0750.120.1940.069-0.0750.084
EPS -0.031-0.04-0.008-0.086-0.12-0.0120.030.037-0.0280.040.0880.0810.0860.0930.0980.110.0610.0940.140.062-0.0760.048
EPS Diluted -0.031-0.04-0.008-0.086-0.12-0.0120.030.037-0.0280.040.0880.0810.0860.0930.0980.110.0610.0940.140.062-0.0750.048
EBITDA 54.13537.5411.0925.98226.1140.8959.45539.0535.36238.95147.08154.72559.56256.85362.43962.1454.34851.5745.00252.54818.38444.369
EBITDA Ratio 0.1010.0790.0280.0690.0730.1130.0270.1140.1040.1190.1460.1720.20.1920.2220.2180.2230.2180.2060.240.0880.221